Kingchem (Liaoning) Life Science Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000066M6
CNY
39.65
1.17 (3.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company has declared positive results in Mar'2025 after 4 consecutive negative quarters

  • NET SALES(Q) At CNY 174.75 MM has Grown at 42.66%
  • PRE-TAX PROFIT(Q) At CNY 55.56 MM has Grown at 176.83%
  • NET PROFIT(Q) At CNY 46.83 MM has Grown at 179.72%
2

With ROE of 3.51%, it has a attractive valuation with a 0.33 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 698 Million (Micro Cap)

stock-summary
P/E

10.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.17%

stock-summary
Debt Equity

-0.26

stock-summary
Return on Equity

4.51%

stock-summary
Price to Book

0.32

Revenue and Profits:
Net Sales:
138 Million
(Quarterly Results - Sep 2025)
Net Profit:
32 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.09%
0%
3.09%
6 Months
0.25%
0%
0.25%
1 Year
56.97%
0%
56.97%
2 Years
-4.44%
0%
-4.44%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Kingchem (Liaoning) Life Science Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-13.32%
EBIT Growth (5y)
-49.12%
EBIT to Interest (avg)
61.37
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
0.33
Tax Ratio
8.18%
Dividend Payout Ratio
124.77%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.33%
ROE (avg)
9.44%

Valuation key factors

Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.33
EV to EBIT
-10.77
EV to EBITDA
-4.57
EV to Capital Employed
-0.55
EV to Sales
-0.89
PEG Ratio
NA
Dividend Yield
1.12%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
3.51%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 10.06% vs -18.70% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 340.28% vs -79.01% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "137.80",
          "val2": "125.20",
          "chgp": "10.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.70",
          "val2": "21.50",
          "chgp": "38.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.70",
          "val2": "7.20",
          "chgp": "340.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "215.60%",
          "val2": "39.50%",
          "chgp": "17.61%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -35.31% vs 6.60% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -77.76% vs 7.49% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "494.20",
          "val2": "764.00",
          "chgp": "-35.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "75.90",
          "val2": "261.60",
          "chgp": "-70.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "2.40",
          "chgp": "-79.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.10",
          "val2": "-0.40",
          "chgp": "-675.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "38.60",
          "val2": "173.60",
          "chgp": "-77.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.90%",
          "val2": "253.10%",
          "chgp": "-23.62%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
137.80
125.20
10.06%
Operating Profit (PBDIT) excl Other Income
29.70
21.50
38.14%
Interest
0.00
0.00
Exceptional Items
1.80
0.00
Consolidate Net Profit
31.70
7.20
340.28%
Operating Profit Margin (Excl OI)
215.60%
39.50%
17.61%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 10.06% vs -18.70% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 340.28% vs -79.01% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
494.20
764.00
-35.31%
Operating Profit (PBDIT) excl Other Income
75.90
261.60
-70.99%
Interest
0.50
2.40
-79.17%
Exceptional Items
-3.10
-0.40
-675.00%
Consolidate Net Profit
38.60
173.60
-77.76%
Operating Profit Margin (Excl OI)
16.90%
253.10%
-23.62%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -35.31% vs 6.60% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -77.76% vs 7.49% in Dec 2023

stock-summaryCompany CV
About Kingchem (Liaoning) Life Science Co., Ltd. stock-summary
stock-summary
Kingchem (Liaoning) Life Science Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available